---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011148"
form_type: "8-K"
ticker: "CYCN"
cik: "0001755237"
company_name: "Cyclerion Therapeutics, Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:49:47.808634+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclerion receives Nasdaq deficiency notice for bid price below $1; 180-day cure period to Nov 28, 2022

## Summary
- Received Nasdaq deficiency letter on June 1, 2022, for failing minimum $1 bid price for 30 consecutive business days.
- Has until November 28, 2022, to regain compliance with bid price closing at $1 for 10 consecutive days.
- May transfer to Nasdaq Capital Market or effect a reverse stock split if needed to cure the deficiency.
- No assurance of regaining compliance; failure could lead to delisting and appeal process.

## SEC filing metadata
- accession: 0000950170-22-011148
- form_type: 8-K
- ticker: CYCN
- cik: 0001755237
- company_name: Cyclerion Therapeutics, Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1755237/000095017022011148/0000950170-22-011148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1755237/000095017022011148/cycn-20220603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011148
- JSON: https://secwatch.observer/filing/0000950170-22-011148.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011148.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.